Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Blood Advances
|
August 30, 2021
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
John E Wagner, Karen K Ballen, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 2024
The health risk of social disadvantage is transplantable into a new host
Lucie M Turcotte, Tao Wang, Kirsten M Beyer, et al.
Transplantation and Cellular Therapy
|
June 13, 2024
Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes
Yung-Tsi Bolon, Rasha Atshan, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
January 4, 2025
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes
Paul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
British Journal of Haematology
|
March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2026
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant
Nicole Liberio, Mariam Allbee-Johnson, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy
|
September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy
Nina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
Sagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Transplantation and Cellular Therapy
|
June 29, 2024
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry
Rachel Cusatis, Carlos Litovich, Zhongyu Feng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Blood Advances
|
August 30, 2021
Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning
John E Wagner, Karen K Ballen, Mei-Jie Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 15, 2024
The health risk of social disadvantage is transplantable into a new host
Lucie M Turcotte, Tao Wang, Kirsten M Beyer, et al.
Transplantation and Cellular Therapy
|
June 13, 2024
Leveraging Hematopoietic Cell Transplant Data and Biorepository Resources at the Center for International Blood and Marrow Transplant Research to Improve Patient Outcomes
Yung-Tsi Bolon, Rasha Atshan, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
January 4, 2025
Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
Cindy Lynn Hickey, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
November 14, 2021
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes
Paul V O'Donnell, Claudio G Brunstein, Ephraim J Fuchs, et al.
British Journal of Haematology
|
March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?
Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2026
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant
Nicole Liberio, Mariam Allbee-Johnson, Kwang Woo Ahn, et al.
Transplantation and Cellular Therapy
|
September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid Malignancy
Nina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy
|
March 22, 2022
Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation
Sagar S Patel, Kwang Woo Ahn, Manoj Khanal, et al.
Transplantation and Cellular Therapy
|
June 29, 2024
Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry
Rachel Cusatis, Carlos Litovich, Zhongyu Feng, et al.
Page
of 1